Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025
04:05pm, Tuesday, 23'rd Sep 2025
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, Oct
Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)
05:14am, Wednesday, 17'th Sep 2025
For this year, Medpace expects that its revenues will increase by 17.1%, which is an excellent growth rate. From 2019 to Q2 2025, Medpace's outstanding common shares declined by 22.16%, creating value
SOLV or MEDP: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 16'th Sep 2025
Investors interested in stocks from the Medical Services sector have probably already heard of Solventum (SOLV) and Medpace (MEDP). But which of these two stocks offers value investors a better bang f
Why Medpace (MEDP) Outpaced the Stock Market Today
07:15pm, Monday, 15'th Sep 2025
Medpace (MEDP) reached $496.41 at the closing of the latest trading day, reflecting a +1.18% change compared to its last close.
5 Non-Tech Nasdaq Stocks to Buy That Helped the Index Surge in 2025
10:45am, Thursday, 11'th Sep 2025
Non-tech Nasdaq standouts like HAS, HOOD, IBKR, CELH and MEDP are fueling 2025's index surge.
COR vs. MEDP: Which Stock Is the Better Value Option?
12:41pm, Thursday, 28'th Aug 2025
Investors with an interest in Medical Services stocks have likely encountered both Cencora (COR) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know
01:01pm, Monday, 18'th Aug 2025
Does Medpace (MEDP) have what it takes to be a top stock pick for momentum investors? Let's find out.
Medpace: Return Of The Mack, With Double-Digit Revenue Growth
02:25am, Monday, 04'th Aug 2025
Medpace delivered a stunning Q2 2025, with double-digit revenue and net new awards growth, defying widespread healthcare sector pessimism. The company achieved 14% YoY revenue growth and 18.6% EBITDA
Should You Buy Medpace (MEDP) After Golden Cross?
10:56am, Thursday, 31'st Jul 2025
After reaching an important support level, Medpace Holdings, Inc. (MEDP) could be a good stock pick from a technical perspective. MEDP recently experienced a "golden cross" event, which saw its 50-day
What Makes Medpace (MEDP) a New Strong Buy Stock
01:01pm, Monday, 28'th Jul 2025
Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Momentum Stocks to Buy for July 28th
11:01am, Monday, 28'th Jul 2025
CALX, MEDP and WST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 28, 2025.
New Strong Buy Stocks for July 28th
08:50am, Monday, 28'th Jul 2025
MEDP, CBFV, CALX, TREE and HAS have been added to the Zacks Rank #1 (Strong Buy) List on July 28, 2025.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Friday, 25'th Jul 2025
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Medpace Beats Q2 Revenue Estimates
10:01pm, Tuesday, 22'nd Jul 2025
Medpace (MEDP 54.51%), a clinical contract research organization that manages drug development for pharmaceutical and biotech clients, reported its second quarter 2025 earnings on July 17, 2025. The c
Medpace Holdings, Inc. (MEDP) Q2 2025 Earnings Call Transcript
02:14pm, Tuesday, 22'nd Jul 2025
Medpace Holdings, Inc. (NASDAQ:MEDP ) Q2 2025 Earnings Conference Call July 22, 2025 9:00 AM ET Company Participants August James Troendle - Chairman & CEO Jesse J. Geiger - President Kevin M.
